Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure. | Semantic Scholar
Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction | Journal of the American Heart Association
Inflammation and resolution signaling in cardiac repair and heart failure - eBioMedicine
Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction | Journal of the American Heart Association
Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Journal of the American
Cardiac Marker - an overview | ScienceDirect Topics
The Evolution and Direction of the Cardiac Biomarker | EMJ Reviews
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19 | Hypertension
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association | Circulation
Role of Cardiac Biomarkers in Diagnosing Heart Attack
Markers in Cardiology AHA: Current and Future Clinical Applications by Jesse E. 9780879934729 | eBay
Myocardial infarction - Wikipedia
American Heart Association - an overview | ScienceDirect Topics
Heart Disease and Stroke Statistics—2021 Update | Circulation
High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality | NEJM
Biomarkers in Heart Failure | NEJM
Get With The Guidelines Heart Failure / Target: Heart Failure Workshops and Webinars | American Heart Association
Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text